About this item:

428 Views | 231 Downloads

Author Notes:

Jonathon B. Cohen jonathan.cohen@emory.edu Department of Hematology and Medical Oncology, Emory University – Winship Cancer Institute, 1365C Clifton Road, NE, Atlanta, GA 30322, USA

Disclosure forms provided by the authors are available with the full text of this article online through the link to the Final Published Version.

Subject:

Research Funding:

This study was an investigator initiated study with funding provided by Takeda Pharmaceuticals.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Oncology
  • Hematology
  • KINASE INHIBITOR
  • AURORA
  • MLN8237

A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma

Tools:

Journal Title:

Leukemia & Lymphoma

Volume:

Volume 58, Number 9

Publisher:

, Pages 2268-2269

Type of Work:

Article | Post-print: After Peer Review

Copyright information:

© 2017 Informa UK Limited

Export to EndNote